ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 133 filers reported holding ANIKA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $943,647 | +19.5% | 50,652 | +89.9% | 0.02% | +9.1% |
| Q4 2022 | $789,639 | +118.1% | 26,677 | +75.6% | 0.02% | +69.2% |
| Q3 2022 | $362,000 | -23.3% | 15,192 | -28.2% | 0.01% | -38.1% |
| Q2 2022 | $472,000 | +20.4% | 21,158 | +35.5% | 0.02% | +16.7% |
| Q1 2022 | $392,000 | +80.6% | 15,610 | +211.8% | 0.02% | 0.0% |
| Q2 2021 | $217,000 | -59.3% | 5,006 | -51.3% | 0.02% | -43.8% |
| Q4 2019 | $533,000 | +67.1% | 10,283 | +76.7% | 0.03% | +14.3% |
| Q3 2019 | $319,000 | -10.6% | 5,820 | -50.8% | 0.03% | +12.0% |
| Q1 2019 | $357,000 | +56.6% | 11,820 | +118.8% | 0.02% | +47.1% |
| Q3 2018 | $228,000 | -59.0% | 5,403 | -57.8% | 0.02% | -76.1% |
| Q1 2017 | $556,000 | +96.5% | 12,807 | +43.9% | 0.07% | +195.8% |
| Q3 2015 | $283,000 | -36.3% | 8,900 | -18.5% | 0.02% | -69.6% |
| Q4 2014 | $444,000 | – | 10,919 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |